Adaptive venom evolution and toxicity in octopods is driven by extensive novel gene formation, expansion, and loss.

cephalopod genome comparative genomics gene family expansions transposable elements venom evolution

Journal

GigaScience
ISSN: 2047-217X
Titre abrégé: Gigascience
Pays: United States
ID NLM: 101596872

Informations de publication

Date de publication:
10 11 2020
Historique:
received: 11 05 2020
revised: 10 08 2020
accepted: 06 10 2020
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 26 10 2021
Statut: ppublish

Résumé

Cephalopods represent a rich system for investigating the genetic basis underlying organismal novelties. This diverse group of specialized predators has evolved many adaptations including proteinaceous venom. Of particular interest is the blue-ringed octopus genus (Hapalochlaena), which are the only octopods known to store large quantities of the potent neurotoxin, tetrodotoxin, within their tissues and venom gland. To reveal genomic correlates of organismal novelties, we conducted a comparative study of 3 octopod genomes, including the Southern blue-ringed octopus (Hapalochlaena maculosa). We present the genome of this species and reveal highly dynamic evolutionary patterns at both non-coding and coding organizational levels. Gene family expansions previously reported in Octopus bimaculoides (e.g., zinc finger and cadherins, both associated with neural functions), as well as formation of novel gene families, dominate the genomic landscape in all octopods. Examination of tissue-specific genes in the posterior salivary gland revealed that expression was dominated by serine proteases in non-tetrodotoxin-bearing octopods, while this family was a minor component in H. maculosa. Moreover, voltage-gated sodium channels in H. maculosa contain a resistance mutation found in pufferfish and garter snakes, which is exclusive to the genus. Analysis of the posterior salivary gland microbiome revealed a diverse array of bacterial species, including genera that can produce tetrodotoxin, suggestive of a possible production source. We present the first tetrodotoxin-bearing octopod genome H. maculosa, which displays lineage-specific adaptations to tetrodotoxin acquisition. This genome, along with other recently published cephalopod genomes, represents a valuable resource from which future work could advance our understanding of the evolution of genomic novelty in this family.

Sections du résumé

BACKGROUND
Cephalopods represent a rich system for investigating the genetic basis underlying organismal novelties. This diverse group of specialized predators has evolved many adaptations including proteinaceous venom. Of particular interest is the blue-ringed octopus genus (Hapalochlaena), which are the only octopods known to store large quantities of the potent neurotoxin, tetrodotoxin, within their tissues and venom gland.
FINDINGS
To reveal genomic correlates of organismal novelties, we conducted a comparative study of 3 octopod genomes, including the Southern blue-ringed octopus (Hapalochlaena maculosa). We present the genome of this species and reveal highly dynamic evolutionary patterns at both non-coding and coding organizational levels. Gene family expansions previously reported in Octopus bimaculoides (e.g., zinc finger and cadherins, both associated with neural functions), as well as formation of novel gene families, dominate the genomic landscape in all octopods. Examination of tissue-specific genes in the posterior salivary gland revealed that expression was dominated by serine proteases in non-tetrodotoxin-bearing octopods, while this family was a minor component in H. maculosa. Moreover, voltage-gated sodium channels in H. maculosa contain a resistance mutation found in pufferfish and garter snakes, which is exclusive to the genus. Analysis of the posterior salivary gland microbiome revealed a diverse array of bacterial species, including genera that can produce tetrodotoxin, suggestive of a possible production source.
CONCLUSIONS
We present the first tetrodotoxin-bearing octopod genome H. maculosa, which displays lineage-specific adaptations to tetrodotoxin acquisition. This genome, along with other recently published cephalopod genomes, represents a valuable resource from which future work could advance our understanding of the evolution of genomic novelty in this family.

Identifiants

pubmed: 33175168
pii: 5974087
doi: 10.1093/gigascience/giaa120
pmc: PMC7656900
pii:
doi:

Substances chimiques

Venoms 0
Tetrodotoxin 4368-28-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Science Fund FWF
ID : P 30686
Pays : Austria

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press GigaScience.

Références

Gigascience. 2018 Feb 1;7(2):
pubmed: 29267857
Toxins (Basel). 2017 Jul 26;9(8):
pubmed: 28933727
Toxicon. 2019 Dec;170:77-84
pubmed: 31550451
Cell. 2010 Oct 29;143(3):343-53
pubmed: 21029858
J Proteome Res. 2016 Sep 2;15(9):3284-97
pubmed: 27427999
J Morphol. 1976 Nov;150(3):639-79
pubmed: 1003488
Nucleic Acids Res. 2019 Jul 2;47(W1):W5-W10
pubmed: 31062021
Toxicol Lett. 2017 Oct 5;280:159-170
pubmed: 28847519
Toxicon. 1976;14(6):423-6
pubmed: 1014030
J Cell Biol. 1964 Apr;21:87-103
pubmed: 14154498
Nature. 2015 Aug 13;524(7564):220-4
pubmed: 26268193
BMC Genomics. 2015 Jun 09;16:441
pubmed: 26054852
Am J Emerg Med. 2003 Jan;21(1):51-4
pubmed: 12563582
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Curr Biol. 2009 Jul 28;19(14):R584-94
pubmed: 19640497
Food Chem Toxicol. 1995 Nov;33(11):929-34
pubmed: 7590540
Genome Biol. 2003;4(3):207
pubmed: 12620097
Peptides. 2003 Jan;24(1):35-43
pubmed: 12576083
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):146-56
pubmed: 10708855
J Proteome Res. 2018 Nov 2;17(11):3866-3876
pubmed: 30220204
Bioinformatics. 2017 Jul 15;33(14):2202-2204
pubmed: 28369201
Gigascience. 2018 Sep 1;7(9):
pubmed: 30107526
Mol Phylogenet Evol. 2018 Jan;118:330-342
pubmed: 28989097
Sci Data. 2019 Apr 1;6(1):13
pubmed: 30931949
Gigascience. 2018 Nov 1;7(11):
pubmed: 30256935
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):803-8
pubmed: 11792858
Mol Phylogenet Evol. 2005 Oct;37(1):235-48
pubmed: 16009571
Nature. 2012 Oct 4;490(7418):49-54
pubmed: 22992520
Nat Biotechnol. 2011 May 15;29(7):644-52
pubmed: 21572440
Toxicon. 1985;23(2):271-6
pubmed: 4024136
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8714-9
pubmed: 11447285
PLoS One. 2012;7(2):e32269
pubmed: 22359676
J Mol Evol. 2013 Apr;76(4):192-204
pubmed: 23456102
Mol Ecol. 2016 Jan;25(1):142-56
pubmed: 26290347
Cell Mol Life Sci. 2017 Nov;74(22):4133-4157
pubmed: 28631008
Bioinformatics. 2014 May 1;30(9):1236-40
pubmed: 24451626
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3030-3035
pubmed: 30635418
Toxicon. 1985;23(6):997-9
pubmed: 3006286
J Mol Evol. 2009 Apr;68(4):311-21
pubmed: 19294452
Toxicon. 2009 Sep 1;54(3):345-53
pubmed: 19481562
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Toxicon. 1966 Mar;3(3):195-203
pubmed: 5938783
Bioessays. 2019 Dec;41(12):e1900073
pubmed: 31664724
Genome Biol Evol. 2014 Mar;6(3):510-25
pubmed: 24534434
Biochimie. 2012 Dec;94(12):2740-8
pubmed: 22940594
DNA Res. 2014 Feb;21(1):85-101
pubmed: 24107803
Sci Data. 2019 Feb 19;6:190022
pubmed: 30778257
Nucleic Acids Res. 2003 Oct 1;31(19):5654-66
pubmed: 14500829
Toxins (Basel). 2017 May 17;9(5):
pubmed: 28513564
Nat Rev Neurosci. 2016 Jan;17(1):22-35
pubmed: 26656254
Nucleic Acids Res. 2019 Jul 2;47(W1):W52-W58
pubmed: 31053848
Aquat Toxicol. 2014 Jan;146:205-11
pubmed: 24316438
Annu Rev Genet. 1977;11:49-78
pubmed: 413473
Ann N Y Acad Sci. 1986;479:68-83
pubmed: 2434009
Mol Biol Evol. 2014 Nov;31(11):2836-46
pubmed: 25135948
Curr Biol. 2018 Nov 5;28(21):3373-3382.e5
pubmed: 30344117
Curr Biol. 2018 Feb 19;28(4):R144-R145
pubmed: 29462576
Evodevo. 2010 Nov 05;1(1):12
pubmed: 21054859
Toxicon. 2002 Jun;40(6):677-83
pubmed: 12175603
Front Physiol. 2019 Jan 14;9:1905
pubmed: 30692932
Syst Biol. 2003 Oct;52(5):696-704
pubmed: 14530136
Appl Environ Microbiol. 2000 Apr;66(4):1698-701
pubmed: 10742263
Nat Ecol Evol. 2019 Mar;3(3):469-478
pubmed: 30804520
Nat Genet. 2014 Aug;46(8):919-25
pubmed: 24952747
Comp Gen Pharmacol. 1972 Jun;3(10):244-8
pubmed: 4667140
BMC Bioinformatics. 2011 Sep 30;12:385
pubmed: 21961884
J Exp Biol. 2012 Nov 1;215(Pt 21):3752-7
pubmed: 23053367
Toxicon. 1987;25(2):225-8
pubmed: 3576639
Evolution. 1990 May;44(3):651-659
pubmed: 28567972
Gigascience. 2017 Aug 1;6(8):1-12
pubmed: 28873964
BMC Bioinformatics. 2016 Sep 29;17(1):399
pubmed: 27687690
Aquat Toxicol. 2019 Jan;206:114-122
pubmed: 30472480
Toxicon. 2000 Jun;38(6):825-39
pubmed: 10695968
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4556-61
pubmed: 22392995
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
Cell Rep. 2017 Jan 17;18(3):762-776
pubmed: 28099853
Peptides. 2013 Sep;47:71-6
pubmed: 23850991
PLoS One. 2014 Jul 23;9(7):e102115
pubmed: 25054971
Nat Ecol Evol. 2017 Apr 03;1(5):121
pubmed: 28812709
Mol Cell Proteomics. 2010 Nov;9(11):2369-90
pubmed: 20631207
Toxins (Basel). 2018 Oct 11;10(10):
pubmed: 30314373
Toxicon. 2002 Feb;40(2):131-6
pubmed: 11689234
Toxicon. 2007 Mar 1;49(3):410-2
pubmed: 17188731
Mar Drugs. 2013 Aug 02;11(8):2695-712
pubmed: 23917066
J Biol Chem. 2009 Dec 4;284(49):33869-75
pubmed: 19828457
Proc Biol Sci. 2017 Mar 15;284(1850):
pubmed: 28250188
Toxicon. 1977;15(5):463-6
pubmed: 906032
Toxicon. 2012 Dec 1;60(7):1307-13
pubmed: 22983011
Parasitology. 1997 Sep;115 ( Pt 3):289-96
pubmed: 9300466
Biochemistry. 1981 Jun 9;20(12):3517-22
pubmed: 6789871
Mol Biol Evol. 2008 Jun;25(6):1016-24
pubmed: 18258611
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Nat Rev Mol Cell Biol. 2000 Nov;1(2):91-100
pubmed: 11253370
Mol Biol Evol. 2018 Mar 1;35(3):543-548
pubmed: 29220515
Nature. 2011 Jul 13;475(7357):493-6
pubmed: 21753753
Genome Biol. 2010;11(9):R95
pubmed: 20920228
Toxicol Lett. 2018 May 15;288:119-128
pubmed: 29462691
Toxicon. 2017 Oct;137:19-26
pubmed: 28711466
Toxicon. 2005 Sep 15;46(4):471-6
pubmed: 16051296
DNA Res. 2018 Dec 1;25(6):655-665
pubmed: 30295708
Science. 2018 Oct 19;362(6412):
pubmed: 30049784
Toxicon. 2005 Jun 15;45(8):969-85
pubmed: 15922769

Auteurs

Brooke L Whitelaw (BL)

Centre for Sustainable Tropical Fisheries and Aquaculture, James Cook University, 1 James Cook Dr, Douglas QLD 4811 , Australia.
Sciences, Museum Victoria, 11 Nicholson St, Carlton, Victoria 3053, Australia.

Ira R Cooke (IR)

College of Public Health, Medical and Vet Sciences, James Cook University,1 James Cook Dr, Douglas QLD 4811 , Australia.
La Trobe Institute of Molecular Science, La Trobe University, Plenty Rd &, Kingsbury Dr, Bundoora, Melbourne, Victoria 3086, Australia.

Julian Finn (J)

Sciences, Museum Victoria, 11 Nicholson St, Carlton, Victoria 3053, Australia.

Rute R da Fonseca (RR)

Center for Macroecology, Evolution and Climate (CMEC), GLOBE Institute, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen, Denmark.

Elena A Ritschard (EA)

Department of Neurosciences and Developmental Biology, University of Vienna,Universitätsring 1, 1010 Wien, Vienna, Austria.
Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, Naples, Italy.

M T P Gilbert (MTP)

Center for Evolutionary Hologenomics, GLOBE Institute, University of Copenhagen, Øster Voldgade 5-7, 1350 Copenhagen, Denmark.

Oleg Simakov (O)

Department of Neurosciences and Developmental Biology, University of Vienna,Universitätsring 1, 1010 Wien, Vienna, Austria.

Jan M Strugnell (JM)

Centre for Sustainable Tropical Fisheries and Aquaculture, James Cook University, 1 James Cook Dr, Douglas QLD 4811 , Australia.
Department of Ecology, Environment and Evolution, La Trobe University, Plenty Rd &, Kingsbury Dr, Bundoora, Melbourne, Victoria 3086, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH